Literature DB >> 317095

Long-chain F-18 fatty acids for the study of regional metabolism in heart and liver; odd-even effects of metabolism in mice.

E J Knust, C Kupfernagel, G Stöcklin.   

Abstract

In view of the potential usefulness of fluorine-tagged fatty acids in the study of regional metabolism in the heart and liver, the time courses of uptake and release of 9,10-[18F]fluorostearic acid, 2-[18F]fluorostearic acid, 16-[18F]fluorohexadecanoic acid, 17-[18F]fluoroheptadecanoic acid have been investigated in several organs of NMRI mice. Whereas 2-[18F]fluorostearic acid shows very little uptake in the heart muscle but an increasing accumulation in the liver, the fatty acids with the F-18 label in the middle or at the end of the carbon chain exhibit uptake and elimination behavior similar to that of the analogous C-11-labeled compounds. After rapid concentration in the heart within 1 min, clearance takes place with fast and slow components. 16-[18F]fluorohexadecanoic acid and 17-[18F]fluoroheptadecanoic acid have different half-times of elimination. These differences are also reflected by the fact that nearly all the activity present in the heart can be recovered as fluoride(F-18) in the case of 17-[18F]fluoroheptadecanoic acid, whereas practically no fluoride was found among the metabolites of 16-[18F]fluorohexadecanoic acid. Similar differences were observed for the F-18 activity in bone. The results can be interpreted in terms of the odd-even rule: beta oxidation of even-numbered fatty acids ends up with [18F]fluoroacetic acid, whereas the odd-numbered fatty acids give rise to beta-[18F]fluoropropionic acid. Only in the latter case does dehalogenation take place leading to free fluoride, whereas fluoroacetic acid undergoes further reactions in the citric acid cycle.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 317095

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

Review 1.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

Review 2.  Imaging of myocardial fatty acid oxidation.

Authors:  Kieren J Mather; Timothy R DeGrado
Journal:  Biochim Biophys Acta       Date:  2016-02-27

Review 3.  Positron emission tomography.

Authors:  Y L Yamamoto; C J Thompson; M Diksic; E Meyer; W H Feindel
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

4.  Preclinical in vivo and in vitro comparison of the translocator protein PET ligands [18F]PBR102 and [18F]PBR111.

Authors:  S Eberl; A Katsifis; M A Peyronneau; L Wen; D Henderson; C Loc'h; I Greguric; J Verschuer; T Pham; P Lam; F Mattner; A Mohamed; M J Fulham
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-04       Impact factor: 9.236

5.  Omega-halofatty acids: a probe for mitochondrial membrane integrity. In vitro investigations in normal and ischaemic myocardium.

Authors:  G Kloster; G Stöcklin; E F Smith; K Schrör
Journal:  Eur J Nucl Med       Date:  1984

6.  Structure dependence of long-chain [18F]fluorothia fatty acids as myocardial fatty acid oxidation probes.

Authors:  Mukesh K Pandey; Anthony P Belanger; Shuyan Wang; Timothy R DeGrado
Journal:  J Med Chem       Date:  2012-11-27       Impact factor: 7.446

7.  Dynamic myocardial scintigraphy with 123I-labeled free fatty acids in patients with myocardial infarction.

Authors:  E E van der Wall; W den Hollander; G A Heidendal; G Westera; P A Majid; J P Roos
Journal:  Eur J Nucl Med       Date:  1981

8.  2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.

Authors:  Nagavarakishore Pillarsetty; Blesida Punzalan; Steven M Larson
Journal:  J Nucl Med       Date:  2009-09-16       Impact factor: 10.057

9.  Liver uptake of free fatty acids in vivo in humans as determined with 14( R, S)-[18F]fluoro-6-thia-heptadecanoic acid and PET.

Authors:  Patricia Iozzo; Anu K Turpeinen; Teemu Takala; Vesa Oikonen; Olof Solin; Ele Ferrannini; Pirjo Nuutila; Juhani Knuuti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-06-17       Impact factor: 9.236

10.  I-123 heptadecanoic acid--value and limitations in comparison with C-11 palmitate.

Authors:  H R Schön
Journal:  Eur J Nucl Med       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.